The global compression therapy market size was estimated to be US$ 3.95 billion in 2021 and is expected to grow at a CAGR of 6.3% between 2023 to 2032.
To improve blood flow in the legs, compression therapy involves wearing stockings, socks, or other elastic clothing designed to support and contain veins. It improves circulation to relieve swelling and soreness in the legs and return to normal leg function. The compression stockings allow for the reduction of vein cavities and venous pressure, preventing venous stasis and venous walk impairment.
An elastic device is used in medical compression therapy to apply controlled pressure to limbs or other body parts. As a result, the device tightens the vein walls and improves circulation. Compression therapy is most frequently employed to reduce swelling and improve leg circulation following surgery. Calf muscles typically contract and relax regularly during leg activity like walking to help the heart pump blood from the lower extremities. Blood clots may form when a person is immobile for an extended period of time, such as while recovering from surgery.
Medical compression also helps to reduce inflammation and to create conditions that are suitable for the treatment of acute inflammatory disorders.
Popular therapies on the market include:
Globally, the prevalence of lymphatic and venous illnesses is rising quickly. Varicose veins, pregnancy, obesity, past deep vein thrombosis, and immobility are among the risk factors contributing to these illnesses' development. Additionally, conditions including breast cancer, chronic venous insufficiency, and operations cause lymphatic problems.
Therefore, rising knowledge of cutting-edge therapies, including compression garments and other gadgets, and the rising prevalence of these disorders will probably fuel market expansion. For instance, venous leg ulceration, which affects 1.5% of the general population and up to 5% of the elderly, is the most prevalent medical problem in the world, according to an article in Vascular Medicine.
Compression therapy is expected to have several new advancements throughout the forecast period, fuelling market expansion. Advanced compression therapy systems are multi-component, bi-layer alternatives to traditional treatment choices like single-component compression systems.
The multi-component system comprises a crepe layer, wool padding, an elastic bandage, and a cohesive elastic bandage. With the addition of each layer of compression, the interface pressure under the bandages rises, making multiple systems superior and more efficient than single-component systems. Additionally, a growing number of major players in the market are concentrating on creating advanced compression therapy systems with increased efficacy.
The three product-based market segments are compression Pumps, Compression Garments, and Compression Braces. Compression bandages and wraps, compression stockings, and other compression garments are other categories of compression apparel. Since doctors frequently employ compression garments to treat conditions like lymphedema, venous leg ulcers, gravity eczema, varicose veins, and deep vein thrombosis, it is projected that the compression garments segment will dominate this market.
Compression apparel's expanding use in sports medicine is another factor driving the segment's expansion. Due to the rising incidence of cancer, the rising frequency of chronic venous disorders, and the rising number of hip and knee injury procedures worldwide, compression pumps are projected to be the product sector in the compression therapy market that grows the fastest.
The market is divided into static and dynamic compression therapy based on technique. The technology market was dominated by static compression therapy because of its high ease and user-friendliness. Due to these products’ better accessibility in treating swelling and sports-related injuries to enable pain and pressure alleviation, they account for a significant position in this market. Due to its advantages, such as external control, high venous return, and prolonged effect, dynamic compression therapy is anticipated to experience exponential growth throughout the forecast period. Groups continuously work to raise awareness of its applicability in particular circumstances.
The market is segmented into hospitals & clinics, nursing homes, home care, and others based on the end user. Due to the rising hospitalization rate and the increased use of compression therapy in hospitals, the hospital segment is predicted to hold the biggest market share over the forecasted period.
Additionally, the ease of access to cutting-edge products, the presence of qualified healthcare professionals, and advantageous reimbursement for this therapy will likely help hospitals take the lead in the market. The industry with the greatest CAGR is expected to see growth in 2026 in the home care segment. This is a result of factors including the rise in elderly patients and the rising popularity of items used in home care settings to treat venous and lymphatic problems.
North America dominated the global market in 2021. The increase in the number of older adults and obesity are to blame for the increase in this region's proportion over the previous years. In this region, the availability of advantageous government reimbursement programmes and rising healthcare awareness are also important growth drivers.
Furthermore, a significant factor boosting the market's expansion in this region is the rising prevalence of chronic vein disorders (CVD).
Throughout the predicted period, Asia Pacific is expected to see profitable growth. The market is fueled by significant R&D expenditures by key competitors and persistent efforts to commercialize goods at a substantially reduced cost. Additionally, increasing disposable income increases the likelihood that these products will be used, and ongoing healthcare infrastructure upgrades are predicted to offer the market lucrative growth prospects.
In many developing nations, there needs to be more awareness regarding compression therapy as a viable alternative for treating lymphatic and venous problems, which is expected to limit market expansion. The high cost associated with compression pumps is another important barrier to the market's expansion.
However, growing initiatives by leading players to raise consumer awareness about the availability of this therapy in the market for the treatment of venous leg ulcers, lymphedema, etc., are likely to leverage expansion opportunities in the coming years. These factors are driving up pricing pressure and increasing competition.
Sanyleg S.R.L., Cardinal Health, Sigvaris, 3M Company, Medi GmbH & Co. Kg, Smith & Nephew, Paul Hartmann AG, Medtronic PLC, Bio Compression Systems, and BSN Medical are the major players in the market.
By Product
By Technology:
By Application
By Geography:
The compression therapy market is expected to grow at a CAGR of 6.3% between 2023 to 2032.
The compression therapy market size was estimated to be US$ 3.95 billion in 2021.
According to estimates, the market in the North American region will dominate in terms of sales. The North American market for compression treatment devices is estimated to be worth US$ 1.3 billion and will grow at a CAGR of 5.5 percent over the following five years.
A high-impact rendering driver increases the frequency of vein disorders like leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots. The market is expanding as more products, particularly stockings and bandages, are used to treat the disorders.
Due to the growing use of static compression therapy in treating vascular and orthopedic conditions, the global static compression therapy market is anticipated to be worth more than USD 3 billion by 2030.
Sanyleg S.R.L., Cardinal Health, Sigvaris, 3M Company, Medi GmbH & Co. Kg, Smith & Nephew, Paul Hartmann AG, Medtronic PLC, Bio Compression Systems, and BSN Medical are the major players in the market.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved